BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 018179
(359 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 43/96 (44%), Positives = 56/96 (58%), Gaps = 1/96 (1%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD-HFFNEV 316
FS L+ A++ F N LG+GG G VYKG L G VAVKRL TQ + F EV
Sbjct: 19 RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352
+IS H+NL++L G +T E LLVY ++ N S+
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 42/96 (43%), Positives = 55/96 (57%), Gaps = 1/96 (1%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD-HFFNEV 316
FS L+ A++ F N LG+GG G VYKG L G VAVKRL Q + F EV
Sbjct: 27 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352
+IS H+NL++L G +T E LLVY ++ N S+
Sbjct: 87 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 61/109 (55%), Gaps = 11/109 (10%)
Query: 258 NFSYETLEKATNYFHES------NKLGQGGSGSVYKGTLPGGEAVAVKRLF----YNTTQ 307
+FS+ L+ TN F E NK+G+GG G VYKG + VAVK+L T +
Sbjct: 8 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
F E+ +++ H+NLV+LLG S G + LVY ++PN SLLD L
Sbjct: 67 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 115
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 61/109 (55%), Gaps = 11/109 (10%)
Query: 258 NFSYETLEKATNYFHES------NKLGQGGSGSVYKGTLPGGEAVAVKRLF----YNTTQ 307
+FS+ L+ TN F E NK+G+GG G VYKG + VAVK+L T +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
F E+ +++ H+NLV+LLG S G + LVY ++PN SLLD L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 61/109 (55%), Gaps = 11/109 (10%)
Query: 258 NFSYETLEKATNYFHES------NKLGQGGSGSVYKGTLPGGEAVAVKRLF----YNTTQ 307
+FS+ L+ TN F E NK+G+GG G VYKG + VAVK+L T +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
F E+ +++ H+NLV+LLG S G + LVY ++PN SLLD L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 58/109 (53%), Gaps = 11/109 (10%)
Query: 258 NFSYETLEKATNYFHES------NKLGQGGSGSVYKGTLPGGEAVAVKRLF----YNTTQ 307
+FS+ L+ TN F E NK G+GG G VYKG + VAVK+L T +
Sbjct: 5 SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
F E+ + + H+NLV+LLG S G + LVY + PN SLLD L
Sbjct: 64 LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL 112
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 34/86 (39%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 38 HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 334 SITGPESLLVYEFVPNQSLLDNLFGC 359
P +V E++P +LLD L C
Sbjct: 97 CTLEPPFYIVTEYMPYGNLLDYLREC 122
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 4/110 (3%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWV 309
A++ S N+ +E+ +KLG G G VY+G VAVK L +T + V
Sbjct: 2 AMDPSSPNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
+ F E ++ I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 59 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 108
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 4/110 (3%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWV 309
A++ S N+ +E+ +KLG G G VY+G VAVK L +T + V
Sbjct: 2 AMDPSSPNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
+ F E ++ I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 59 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 108
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 4/110 (3%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWV 309
A++ S N+ +E+ +KLG G G VY+G VAVK L +T + V
Sbjct: 2 AMDPSSPNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
+ F E ++ I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 59 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 108
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 2/104 (1%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNE 315
++ +Y+ E +KLG G G VY+G VAVK L +T + V+ F E
Sbjct: 3 MDPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
++ I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 62 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 105
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 35/95 (36%), Positives = 54/95 (56%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
LE+ATN F +G G G VYKG L G VA+KR ++Q ++ F E+ +S
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFG 358
H +LV L+G E +L+Y+++ N +L +L+G
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 35/95 (36%), Positives = 54/95 (56%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
LE+ATN F +G G G VYKG L G VA+KR ++Q ++ F E+ +S
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFG 358
H +LV L+G E +L+Y+++ N +L +L+G
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC 103
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC 103
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 64
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 65 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC 104
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
KLG G G V +G P G+ V+V K + + +D F EVN + ++H+NL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++L G +T P +V E P SLLD L
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSLLDRL 105
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
KLG G G V +G P G+ V+V K + + +D F EVN + ++H+NL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++L G +T P +V E P SLLD L
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSLLDRL 105
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
KLG G G V +G P G+ V+V K + + +D F EVN + ++H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++L G +T P +V E P SLLD L
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRL 101
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
KLG G G V +G P G+ V+V K + + +D F EVN + ++H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++L G +T P +V E P SLLD L
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRL 101
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 68
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 69 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC 108
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
KLG G G V +G P G+ V+V K + + +D F EVN + ++H+NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++L G +T P +V E P SLLD L
Sbjct: 84 IRLYGVVLTPPMK-MVTELAPLGSLLDRL 111
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
KLG G G V +G P G+ V+V K + + +D F EVN + ++H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++L G +T P +V E P SLLD L
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRL 101
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 2/104 (1%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNE 315
++ +Y+ E +KLG G G VY+G VAVK L +T + V+ F E
Sbjct: 2 MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 60
Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
++ I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 61 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 104
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 17 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 334 SITGPESLLVYEFVPNQSLLDNLFGC 359
P ++ EF+ +LLD L C
Sbjct: 76 CTREPPFYIIIEFMTYGNLLDYLREC 101
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
KLG G G V +G P G+ V+V K + + +D F EVN + ++H+NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++L G +T P +V E P SLLD L
Sbjct: 84 IRLYGVVLTPPMK-MVTELAPLGSLLDRL 111
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 103
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 103
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 2/104 (1%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNE 315
++ +Y+ E +KLG G G VY+G VAVK L +T + V+ F E
Sbjct: 3 MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
++ I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 62 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 105
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 103
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 103
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 17 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 334 SITGPESLLVYEFVPNQSLLDNLFGC 359
P ++ EF+ +LLD L C
Sbjct: 76 CTREPPFYIITEFMTYGNLLDYLREC 101
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 2/104 (1%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNE 315
++ +Y+ E +KLG G G VY+G VAVK L +T + V+ F E
Sbjct: 3 MSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
++ I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 62 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 105
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 67
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 107
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 68
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 69 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 108
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 33/87 (37%), Positives = 45/87 (51%), Gaps = 2/87 (2%)
Query: 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 31 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFGC 359
P ++ EF+ +LLD L C
Sbjct: 90 VCTREPPFYIITEFMTYGNLLDYLREC 116
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+KLG G G VY+G VAVK L +T + V+ F E ++ I H NLV+LLG
Sbjct: 17 HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 334 SITGPESLLVYEFVPNQSLLDNLFGC 359
P ++ EF+ +LLD L C
Sbjct: 76 CTREPPFYIITEFMTYGNLLDYLREC 101
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 270
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 209 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 267
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 268 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 307
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 2/100 (2%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLI 319
Y+ E +KLG G G VY+G VAVK L +T + V+ F E ++
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 309
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFGC 359
I H NLV+LLG P ++ EF+ +LLD L C
Sbjct: 310 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 349
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLD 354
VKLL T + LV+EF+ +Q L D
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKD 90
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 10/90 (11%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYN----TTQWVD---HFFNEVNL 318
A N ++G+GG G V+KG L ++V A+K L T+ ++ F EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVP 348
+S +NH N+VKL G P +V EFVP
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 10/90 (11%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYN----TTQWVD---HFFNEVNL 318
A N ++G+GG G V+KG L ++V A+K L T+ ++ F EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVP 348
+S +NH N+VKL G P +V EFVP
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 10/90 (11%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYN----TTQWVD---HFFNEVNL 318
A N ++G+GG G V+KG L ++V A+K L T+ ++ F EV +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVP 348
+S +NH N+VKL G P +V EFVP
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVP 104
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/83 (37%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ I H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 84 EEP-IYIVTEYMSKGSLLDFLKG 105
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 36/110 (32%), Positives = 57/110 (51%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N+++L ET K LG G G+VYKG +P GE VA+K L T
Sbjct: 26 APNQAQLRILKETELKRVKV------LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 79
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ F +E +++ ++H +LV+LLG ++ P LV + +P+ LL+
Sbjct: 80 GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLE 128
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 36/110 (32%), Positives = 57/110 (51%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N+++L ET K LG G G+VYKG +P GE VA+K L T
Sbjct: 3 APNQAQLRILKETELKRVKV------LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 56
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ F +E +++ ++H +LV+LLG ++ P LV + +P+ LL+
Sbjct: 57 GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLE 105
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL 83
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL 83
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL 85
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 22 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 82 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 110
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 67 VKLLDVIHTENKLYLVFEFL 86
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL 83
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL 83
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL 85
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 21 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 81 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 109
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 67 VKLLDVIHTENKLYLVFEFL 86
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 69 VKLLDVIHTENKLYLVFEFL 88
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 67 VKLLDVIHTENKLYLVFEFL 86
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL 85
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL 85
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 23 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 83 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 111
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 67 VKLLDVIHTENKLYLVFEFL 86
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 17 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 77 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 105
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 15 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 75 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 103
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 20 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 108
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G +G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 19 ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 77 VTQEPIYIITEYMENGSLVDFL 98
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 69 VKLLDVIHTENKLYLVFEFL 88
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 14 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 102
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 72 VKLLDVIHTENKLYLVFEFL 91
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL 85
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 72 VKLLDVIHTENKLYLVFEFL 91
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 35 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 15 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 74 EEP-IXIVTEYMSKGSLLDFLKG 95
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 34 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ E++P SL D L
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 84 EEP-IYIVIEYMSKGSLLDFLKG 105
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKG 271
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKG 271
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 84 EEP-IYIVIEYMSKGSLLDFLKG 105
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+LG+G GSV Y GE VAVK+L ++T + + F E+ ++ + H N+VK
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNL 356
G C G +L L+ EF+P SL + L
Sbjct: 80 KGVCYSAGRRNLKLIMEFLPYGSLREYL 107
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
+Y K+G+G +G V T+ G+ VAVK++ Q + FNEV ++ H+N+
Sbjct: 20 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLD 354
V++ + G E +V EF+ +L D
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTD 106
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 18 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 77 EEP-IYIVTEYMSKGSLLDFLKG 98
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 16 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 75 EEP-IYIVTEYMSKGSLLDFLKG 96
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 14 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 73 EEP-IYIVTEYMSKGSLLDFLKG 94
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
+Y K+G+G +G V T+ G+ VAVK++ Q + FNEV ++ H+N+
Sbjct: 29 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLD 354
V++ + G E +V EF+ +L D
Sbjct: 89 VEMYNSYLVGDELWVVMEFLEGGALTD 115
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
+Y K+G+G +G V T+ G+ VAVK++ Q + FNEV ++ H+N+
Sbjct: 24 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLD 354
V++ + G E +V EF+ +L D
Sbjct: 84 VEMYNSYLVGDELWVVMEFLEGGALTD 110
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 84 EEP-IYIVTEYMSKGSLLDFLKG 105
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 84 EEP-IYIVTEYMSKGSLLDFLKG 105
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
+Y K+G+G +G V T+ G+ VAVK++ Q + FNEV ++ H+N+
Sbjct: 31 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLD 354
V++ + G E +V EF+ +L D
Sbjct: 91 VEMYNSYLVGDELWVVMEFLEGGALTD 117
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 36/82 (43%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
KLG G G V+ G VAVK L T V F E NL+ + H LV+L
Sbjct: 18 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
++ EF+ SLLD L
Sbjct: 77 TKEEPIYIITEFMAKGSLLDFL 98
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 1/80 (1%)
Query: 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G +G V T+ G+ VAVK++ Q + FNEV ++ H+N+V++
Sbjct: 81 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 335 ITGPESLLVYEFVPNQSLLD 354
+ G E +V EF+ +L D
Sbjct: 141 LVGDELWVVMEFLEGGALTD 160
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFLKG 354
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 81 EEP-IYIVTEYMNKGSLLDFLKG 102
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 22 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 81 EEP-IYIVTEYMNKGSLLDFLKG 102
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 1/80 (1%)
Query: 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G +G V T+ G+ VAVK++ Q + FNEV ++ H+N+V++
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 335 ITGPESLLVYEFVPNQSLLD 354
+ G E +V EF+ +L D
Sbjct: 218 LVGDELWVVMEFLEGGALTD 237
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 250 EEP-IYIVGEYMSKGSLLDFLKG 271
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 84 EEP-IYIVCEYMSKGSLLDFLKG 105
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 1/85 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 335 ITGPESLLVYEFVPNQSLLDNLFGC 359
T P+ +V ++ SL +L
Sbjct: 90 -TAPQLAIVTQWCEGSSLYHHLHAS 113
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+E V
Sbjct: 64 VKLLDVIHTENKLYLVFEHV 83
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 30/80 (37%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+K++ +T T+ V E++L+ +NH N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+E V
Sbjct: 68 VKLLDVIHTENKLYLVFEHV 87
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 25 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 82
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 83 VTQEPIYIITEYMENGSLVDFL 104
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 77 VTQEPIYIITEYMENGSLVDFL 98
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 24 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 81
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 82 VTQEPIYIITEYMENGSLVDFL 103
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 20 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 77
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 78 VTQEPIYIITEYMENGSLVDFL 99
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 77 VTQEPIYIITEYMENGSLVDFL 98
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 21 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 78
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 79 VTQEPIYIITEYMENGSLVDFL 100
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 77 VTQEPIYIITEYMENGSLVDFL 98
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 14 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 71
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 72 VTQEPIYIITEYMENGSLVDFL 93
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 25 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 82
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 83 VTQEPIYIITEYMENGSLVDFL 104
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 74 -TAPQLAIVTQWCEGSSLYHHL 94
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 28 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 85
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 86 VTQEPIYIITEYMENGSLVDFL 107
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 29 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 86
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 87 VTQEPIYIITEYMENGSLVDFL 108
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 27 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 84
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 85 VTQEPIYIITEYMENGSLVDFL 106
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G G VAVK L + D F E NL+ + H+ LV+L
Sbjct: 15 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 72
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+T ++ E++ N SL+D L
Sbjct: 73 VTQEPIYIITEYMENGSLVDFL 94
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 1/85 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 18 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 335 ITGPESLLVYEFVPNQSLLDNLFGC 359
T P+ +V ++ SL +L
Sbjct: 78 -TKPQLAIVTQWCEGSSLYHHLHAS 101
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+ ++ +T T+ V E++L+ +NH N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 3/80 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
F + K+G+G G VYK GE VA+ ++ +T T+ V E++L+ +NH N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFV 347
VKLL T + LV+EF+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL 83
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 1/85 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 335 ITGPESLLVYEFVPNQSLLDNLFGC 359
T P+ +V ++ SL +L
Sbjct: 90 -TKPQLAIVTQWCEGSSLYHHLHAS 113
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ LLD L G
Sbjct: 84 EEP-IYIVMEYMSKGCLLDFLKG 105
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 16 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 76 -TKPQLAIVTQWCEGSSLYHHL 96
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 41 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 101 -TKPQLAIVTQWCEGSSLYHHL 121
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 34 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 94 -TKPQLAIVTQWCEGSSLYHHL 114
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 42 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 102 -TKPQLAIVTQWCEGSSLYHHL 122
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 42 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 102 -TKPQLAIVTQWCEGSSLYHHL 122
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 19 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 79 -TKPQLAIVTQWCEGSSLYHHL 99
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 19 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 79 -TKPQLAIVTQWCEGSSLYHHL 99
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 74 -TKPQLAIVTQWCEGSSLYHHL 94
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G+VYKG G AV + + T Q + F NEV ++ H N++ +G S
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
T P+ +V ++ SL +L
Sbjct: 74 -TKPQLAIVTQWCEGSSLYHHL 94
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 1/80 (1%)
Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G +G V T G+ VAVK++ Q + FNEV ++ +H N+V +
Sbjct: 52 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 335 ITGPESLLVYEFVPNQSLLD 354
+ G E +V EF+ +L D
Sbjct: 112 LVGDELWVVMEFLEGGALTD 131
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L + F E ++ + H+ LV+L
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ SLLD L G
Sbjct: 251 EEP-IYIVTEYMSKGSLLDFLKG 272
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 2/83 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
KLGQG G V+ GT G VA+K L T + F E ++ + H+ LV+L
Sbjct: 25 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFG 358
P +V E++ LLD L G
Sbjct: 84 EEP-IYIVTEYMSKGCLLDFLKG 105
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 36/82 (43%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ G VAVK L T V F E NL+ + H LV+L
Sbjct: 19 KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
++ E++ SLLD L
Sbjct: 78 TREEPIYIITEYMAKGSLLDFL 99
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 39/83 (46%), Gaps = 2/83 (2%)
Query: 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
KLG G G V+ T VAVK + + V+ F E N++ + H LVKL
Sbjct: 20 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 334 SITGPESLLVYEFVPNQSLLDNL 356
+T ++ EF+ SLLD L
Sbjct: 79 -VTKEPIYIITEFMAKGSLLDFL 100
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 45/104 (43%), Gaps = 2/104 (1%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHF 312
+K + + + E KLG G G V+ T VAVK + + V+ F
Sbjct: 166 SKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAF 224
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
E N++ + H LVKL +T ++ EF+ SLLD L
Sbjct: 225 LAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFL 267
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 45/104 (43%), Gaps = 2/104 (1%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHF 312
+K + + + E KLG G G V+ T VAVK + + V+ F
Sbjct: 172 SKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAF 230
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
E N++ + H LVKL +T ++ EF+ SLLD L
Sbjct: 231 LAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFL 273
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 41/80 (51%), Gaps = 1/80 (1%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 335 ITGPESLLVYEFVPNQSLLD 354
+ G E +V E++ SL D
Sbjct: 87 LVGDELWVVMEYLAGGSLTD 106
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V+ GT G VA+K L T + F E ++ + H LV+L
Sbjct: 15 KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
P +V E++ SLLD L
Sbjct: 74 SEEP-IYIVTEYMNKGSLLDFL 94
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 41/80 (51%), Gaps = 1/80 (1%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 335 ITGPESLLVYEFVPNQSLLD 354
+ G E +V E++ SL D
Sbjct: 87 LVGDELWVVMEYLAGGSLTD 106
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 27 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 334 SITGPESLLVYEFVPNQSLLD 354
+ G E +V E++ SL D
Sbjct: 87 YLVGDELWVVMEYLAGGSLTD 107
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 334 SITGPESLLVYEFVPNQSLLD 354
+ G E +V E++ SL D
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD 106
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 41/80 (51%), Gaps = 1/80 (1%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+GQG SG+VY + G+ VA++++ + NE+ ++ + N+V L
Sbjct: 28 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 335 ITGPESLLVYEFVPNQSLLD 354
+ G E +V E++ SL D
Sbjct: 88 LVGDELWVVMEYLAGGSLTD 107
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 15/111 (13%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT 305
G+L + ++ S+L F E +G G G V+ G + VA+K + +
Sbjct: 18 GSLHMVIDPSELTFVQE--------------IGSGQFGLVHLGYWLNKDKVAIKTIKEGS 63
Query: 306 TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
D F E ++ ++H LV+L G + LV+EF+ + L D L
Sbjct: 64 MS-EDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL 113
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 7/86 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKL 330
LG G G+VYKG +P GE VA+K L NT+ + +E +++G+ + +L
Sbjct: 25 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNL 356
LG +T LV + +P LLD++
Sbjct: 85 LGICLTSTVQ-LVTQLMPYGCLLDHV 109
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 271 FHESNKLGQGGSGSVY-KGTLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
F + ++G G G+VY + E VA+K++ Y+ Q W D EV + + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75
Query: 326 NLVKLLGCSITGPESLLVYEF 346
N ++ GC + + LV E+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEY 96
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKL 330
S+ LGQG + +V++G G+ A+K +F N + + VD E ++ +NHKN+VKL
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 331 LGC--SITGPESLLVYEFVPNQSL 352
T +L+ EF P SL
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSL 96
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 13/115 (11%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKR 300
GA+ A N++ L ET F + LG G G+VYKG +P GE VA+K
Sbjct: 1 GAMGEAPNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 301 LFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
L T+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 55 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 108
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 13/115 (11%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKR 300
GA+ A N++ L ET F + LG G G+VYKG +P GE VA+K
Sbjct: 1 GAMGEAPNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 301 LFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
L T+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 55 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 108
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 271 FHESNKLGQGGSGSVY-KGTLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
F + ++G G G+VY + E VA+K++ Y+ Q W D EV + + H
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 114
Query: 326 NLVKLLGCSITGPESLLVYEF 346
N ++ GC + + LV E+
Sbjct: 115 NTIQYRGCYLREHTAWLVMEY 135
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 26/79 (32%), Positives = 39/79 (49%), Gaps = 9/79 (11%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
LG G G VY+G + P VAVK L Y+ +D F E +IS NH+N+V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD-FLMEALIISKFNHQNIV 111
Query: 329 KLLGCSITGPESLLVYEFV 347
+ +G S+ ++ E +
Sbjct: 112 RCIGVSLQSLPRFILLELM 130
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKL 330
S+ LGQG + +V++G G+ A+K +F N + + VD E ++ +NHKN+VKL
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 331 LGC--SITGPESLLVYEFVPNQSL 352
T +L+ EF P SL
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSL 96
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 19/59 (32%), Positives = 31/59 (52%)
Query: 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
S ++G G G+VYKG G AV + ++ T + F NEV ++ H N++ +G
Sbjct: 41 STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 37.4 bits (85), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 13/115 (11%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKR 300
G++ A N++ L ET F + LG G G+VYKG +P GE VA+K
Sbjct: 1 GSMGEAPNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 301 LFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
L T+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 55 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 108
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 36.6 bits (83), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 33/115 (28%), Positives = 57/115 (49%), Gaps = 13/115 (11%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKR 300
G++ A N++ L ET F + LG G G+VYKG +P GE VA+K
Sbjct: 1 GSMGEAPNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 301 LFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
L T+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 55 LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 108
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 36.6 bits (83), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 14/95 (14%)
Query: 256 KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT----TQWVDH 311
+++F+ TLE+ +G GG G VY+ G E VAVK ++ +Q +++
Sbjct: 3 EIDFAELTLEEI---------IGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIEN 52
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346
E L + + H N++ L G + P LV EF
Sbjct: 53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKR-LFYNTTQWVDHF-FN 314
N ++++EK N +G+G G V K G VA+K+ L + + V
Sbjct: 18 NLYFQSMEKYENL----GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
E+ L+ + H+NLV LL LV+EFV + ++LD+L
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL 114
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 36.6 bits (83), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS +NH+N+V+
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 99 CIGVSLQSLPRFILLELM 116
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 36.6 bits (83), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS +NH+N+V+
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 113 CIGVSLQSLPRFILLELM 130
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 36.6 bits (83), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 4 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 57
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 58 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLD 106
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 39/80 (48%), Gaps = 1/80 (1%)
Query: 276 KLGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
K+G+G +G V G VAVK + Q + FNEV ++ H N+V++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 335 ITGPESLLVYEFVPNQSLLD 354
+ G E ++ EF+ +L D
Sbjct: 112 LVGEELWVLMEFLQGGALTD 131
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 36.2 bits (82), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 43/83 (51%), Gaps = 11/83 (13%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNL--ISGINHKNLVKLL--G 332
+G+G G+VYKG+L VAVK + Q +F NE N+ + + H N+ + +
Sbjct: 21 IGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 333 CSITGP---ESLLVYEFVPNQSL 352
+T E LLV E+ PN SL
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSL 99
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 20/120 (16%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESN-----KLGQGGSGSVYKGTL------PGGE 294
G L ++V+ +++ LE F N LG+G G V K T G
Sbjct: 1 GPLSLSVD------AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT 54
Query: 295 AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
VAVK L N + + +E N++ +NH +++KL G CS GP LL+ E+ SL
Sbjct: 55 TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSL 113
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 36.2 bits (82), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 20/120 (16%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESN-----KLGQGGSGSVYKGTL------PGGE 294
G L ++V+ +++ LE F N LG+G G V K T G
Sbjct: 1 GPLSLSVD------AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT 54
Query: 295 AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
VAVK L N + + +E N++ +NH +++KL G CS GP LL+ E+ SL
Sbjct: 55 TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSL 113
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 36.2 bits (82), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 37/120 (30%), Positives = 55/120 (45%), Gaps = 20/120 (16%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESN-----KLGQGGSGSVYKGTL------PGGE 294
G L ++V+ +++ LE F N LG+G G V K T G
Sbjct: 1 GPLSLSVD------AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT 54
Query: 295 AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
VAVK L N + + +E N++ +NH +++KL G CS GP LL+ E+ SL
Sbjct: 55 TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSL 113
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 3/69 (4%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
+ + LG GG+G V+ + VA+K++ Q V H E+ +I ++H N+VK
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 330 LLGCSITGP 338
+ I GP
Sbjct: 73 VF--EILGP 79
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 35.8 bits (81), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 5 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 107
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 7 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 60
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 61 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 109
>pdb|2CWW|A Chain A, Crystal Structure Of Thermus Thermophilus Ttha1280, A
Putative Sam- Dependent Rna Methyltransferase, In
Complex With S-Adenosyl-L- Homocysteine
pdb|2CWW|B Chain B, Crystal Structure Of Thermus Thermophilus Ttha1280, A
Putative Sam- Dependent Rna Methyltransferase, In
Complex With S-Adenosyl-L- Homocysteine
Length = 382
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 21/72 (29%), Positives = 33/72 (45%)
Query: 100 GNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCL 159
GN V ANA +L+R L + + D + F+KG V + ++ VN A +
Sbjct: 257 GNVRVLEANAFDLLRRLEKEGERFDLVVLDPPAFAKGKKDVERAYRAYKEVNLRAIKLLK 316
Query: 160 ENAVSRIASCTQ 171
E + ASC+
Sbjct: 317 EGGILATASCSH 328
>pdb|1WXW|A Chain A, Crystal Structure Of Tt1595, A Putative Sam-Dependent
Methyltransferase From Thermus Thermophillus Hb8
pdb|1WXW|B Chain B, Crystal Structure Of Tt1595, A Putative Sam-Dependent
Methyltransferase From Thermus Thermophillus Hb8
pdb|1WXW|C Chain C, Crystal Structure Of Tt1595, A Putative Sam-Dependent
Methyltransferase From Thermus Thermophillus Hb8
pdb|1WXW|D Chain D, Crystal Structure Of Tt1595, A Putative Sam-Dependent
Methyltransferase From Thermus Thermophillus Hb8
pdb|1WXX|A Chain A, Crystal Structure Of Tt1595, A Putative Sam-Dependent
Methyltransferase From Thermus Thermophillus Hb8
pdb|1WXX|B Chain B, Crystal Structure Of Tt1595, A Putative Sam-Dependent
Methyltransferase From Thermus Thermophillus Hb8
pdb|1WXX|C Chain C, Crystal Structure Of Tt1595, A Putative Sam-Dependent
Methyltransferase From Thermus Thermophillus Hb8
pdb|1WXX|D Chain D, Crystal Structure Of Tt1595, A Putative Sam-Dependent
Methyltransferase From Thermus Thermophillus Hb8
Length = 382
Score = 35.8 bits (81), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 21/72 (29%), Positives = 33/72 (45%)
Query: 100 GNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCL 159
GN V ANA +L+R L + + D + F+KG V + ++ VN A +
Sbjct: 257 GNVRVLEANAFDLLRRLEKEGERFDLVVLDPPAFAKGKKDVERAYRAYKEVNLRAIKLLK 316
Query: 160 ENAVSRIASCTQ 171
E + ASC+
Sbjct: 317 EGGILATASCSH 328
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 5 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 107
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 5 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 107
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 98 CIGVSLQSLPRFILMELM 115
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 4 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 57
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 58 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 106
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 35.8 bits (81), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 3 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 105
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 35.8 bits (81), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 3 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLD 105
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 35.8 bits (81), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 7 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 60
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L++ + +P LLD
Sbjct: 61 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 109
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 35.8 bits (81), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 115 CIGVSLQSLPRFILLELM 132
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 98 CIGVSLQSLPRFILLELM 115
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 35.8 bits (81), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 125 CIGVSLQSLPRFILLELM 142
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 35.8 bits (81), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 99 CIGVSLQSLPRFILLELM 116
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 35.8 bits (81), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 113 CIGVSLQSLPRFILMELM 130
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 99 CIGVSLQSLPRFILLELM 116
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 39/83 (46%), Gaps = 3/83 (3%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
+LG G G V G G VAVK + + D FF E + ++H LVK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 334 SITGPESLLVYEFVPNQSLLDNL 356
S P +V E++ N LL+ L
Sbjct: 73 SKEYP-IYIVTEYISNGCLLNYL 94
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 105 CIGVSLQSLPRFILLELM 122
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 116 CIGVSLQSLPRFILLELM 133
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+H K+G+G G VYK GE A+K RL E++++ + H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLD 354
KL T +LV+E + + LLD
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLD 91
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 90 CIGVSLQSLPRFILLELM 107
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 35.4 bits (80), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+H K+G+G G VYK GE A+K RL E++++ + H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLD 354
KL T +LV+E + + LLD
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLD 91
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 35.4 bits (80), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
LG G G VY+G + P VAVK L ++ + F E +IS NH+N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 330 LLGCSITGPESLLVYEFV 347
+G S+ ++ E +
Sbjct: 139 CIGVSLQSLPRFILLELM 156
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 35.4 bits (80), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
+H K+G+G G VYK GE A+K RL E++++ + H N+V
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLD 354
KL T +LV+E + + LLD
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLD 91
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
F + LG G G+VYKG +P GE VA+K L T+ + +E +++ +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
++ +LLG +T L+ + +P LLD
Sbjct: 71 PHVCRLLGICLTSTVQLIT-QLMPFGCLLD 99
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 35.4 bits (80), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 3 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 105
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 35.4 bits (80), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 10 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 112
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 35.4 bits (80), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 3 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 105
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 35.4 bits (80), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 5 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 107
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 35.4 bits (80), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 3 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 105
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 35.4 bits (80), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 5 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 59 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 107
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 35.4 bits (80), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 10 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 64 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 112
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 35.4 bits (80), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
F + LG G G+VYKG +P GE VA+K L T+ + +E +++ +++
Sbjct: 14 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
++ +LLG +T L+ + +P LLD
Sbjct: 74 PHVCRLLGICLTSTVQLIT-QLMPFGCLLD 102
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 35.4 bits (80), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 13 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 66
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 67 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 115
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 35.0 bits (79), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 28 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 81
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 82 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 130
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 35.0 bits (79), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+K L T
Sbjct: 9 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 62
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 63 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 111
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 35.0 bits (79), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 267 ATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF-FNEVNLISGINH 324
+++ F + KLG G +VYKG G VA+K + ++ + E++L+ + H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 325 KNLVKLLGCSITGPESLLVYEFVPN 349
+N+V+L T + LV+EF+ N
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDN 87
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 35.0 bits (79), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 7/82 (8%)
Query: 277 LGQGGSGSVYKG--TLPGGEAVAVK----RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V G LPG VAV ++ Y Q D F E +++ +H N+V L
Sbjct: 51 IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD-FLCEASIMGQFDHPNVVHL 109
Query: 331 LGCSITGPESLLVYEFVPNQSL 352
G G ++V EF+ N +L
Sbjct: 110 EGVVTRGKPVMIVIEFMENGAL 131
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 35.0 bits (79), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
S+E K + E LG G G V G G VA+K + + D F E ++
Sbjct: 3 SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 58
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++H+ LV+L G ++ E++ N LL+ L
Sbjct: 59 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 95
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 35.0 bits (79), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
S+E K + E LG G G V G G VA+K + + D F E ++
Sbjct: 3 SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 58
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++H+ LV+L G ++ E++ N LL+ L
Sbjct: 59 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 95
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 35.0 bits (79), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
S+E K + E LG G G V G G VA+K + + D F E ++
Sbjct: 2 SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 57
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++H+ LV+L G ++ E++ N LL+ L
Sbjct: 58 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 94
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 35.0 bits (79), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 12/86 (13%)
Query: 271 FHESNKLGQGGSGSVYKGT---------LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG 321
F+ES LGQG ++KG L E V +K L + + FF +++S
Sbjct: 12 FNES--LGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 322 INHKNLVKLLGCSITGPESLLVYEFV 347
++HK+LV G + G E++LV EFV
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFV 94
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 35.0 bits (79), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
S+E K + E LG G G V G G VA+K + + D F E ++
Sbjct: 9 SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 64
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++H+ LV+L G ++ E++ N LL+ L
Sbjct: 65 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 101
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 35.0 bits (79), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 269 NYFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI 322
Y + LG+G G V Y T G GE VAVK L Q + E+ ++ +
Sbjct: 9 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL 68
Query: 323 NHKNLVKLLG-CSITGPESL-LVYEFVPNQSLLDNL 356
H+++VK G C G +S+ LV E+VP SL D L
Sbjct: 69 YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL 104
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 34.7 bits (78), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 269 NYFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI 322
Y + LG+G G V Y T G GE VAVK L Q + E+ ++ +
Sbjct: 8 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL 67
Query: 323 NHKNLVKLLG-CSITGPESL-LVYEFVPNQSLLDNL 356
H+++VK G C G +S+ LV E+VP SL D L
Sbjct: 68 YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL 103
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 34.7 bits (78), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLV 328
+ + K+G+G G VYK G VA+KR+ + E++L+ ++H N+V
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 329 KLLGCSITGPESLLVYEFV 347
L+ + LV+EF+
Sbjct: 83 SLIDVIHSERCLTLVFEFM 101
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 34.7 bits (78), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLV 328
+ + K+G+G G VYK G VA+KR+ + E++L+ ++H N+V
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 329 KLLGCSITGPESLLVYEFV 347
L+ + LV+EF+
Sbjct: 83 SLIDVIHSERCLTLVFEFM 101
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 34.7 bits (78), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
S+E K + E LG G G V G G VA+K + + D F E ++
Sbjct: 18 SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 73
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++H+ LV+L G ++ E++ N LL+ L
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 34.7 bits (78), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
S+E K + E LG G G V G G VA+K + + D F E ++
Sbjct: 18 SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 73
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
++H+ LV+L G ++ E++ N LL+ L
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110
>pdb|3A2E|A Chain A, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|B Chain B, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|C Chain C, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|D Chain D, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
Length = 108
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 134 SKGNVSVHGLAQCWEFVNGSACENCLENAVSRIAS-CTQKEEGRVLNAGCYLRYSTQRF 191
S G + +G A C + ++ S C CL N V+RI S C RV C+++Y + F
Sbjct: 50 SGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 45/84 (53%), Gaps = 7/84 (8%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++V
Sbjct: 21 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 329 KLLGCSITGPESLLVYEFVPNQSL 352
+LLG G +L+V E + + L
Sbjct: 81 RLLGVVSKGQPTLVVMELMAHGDL 104
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G V G G VA+K + + D F E ++ ++H+ LV+L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
++ E++ N LL+ L
Sbjct: 69 TKQRPIFIITEYMANGCLLNYL 90
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 34.3 bits (77), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 275 NKLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNL 327
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL 352
V+LLG G +L+V E + + L
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDL 107
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 275 NKLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNL 327
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++
Sbjct: 22 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL 352
V+LLG G +L+V E + + L
Sbjct: 82 VRLLGVVSKGQPTLVVMELMAHGDL 106
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 45/84 (53%), Gaps = 7/84 (8%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSL 352
+LLG G +L+V E + + L
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDL 107
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 275 NKLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNL 327
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL 352
V+LLG G +L+V E + + L
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDL 107
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 34.3 bits (77), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 275 NKLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNL 327
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL 352
V+LLG G +L+V E + + L
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDL 107
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 45/84 (53%), Gaps = 7/84 (8%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++V
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSL 352
+LLG G +L+V E + + L
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDL 107
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 45/84 (53%), Gaps = 7/84 (8%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
+LGQG G VY+G + GEA VAVK + + + + F NE +++ G ++V
Sbjct: 25 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 329 KLLGCSITGPESLLVYEFVPNQSL 352
+LLG G +L+V E + + L
Sbjct: 85 RLLGVVSKGQPTLVVMELMAHGDL 108
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G V+ G + VA+K + D F E ++ ++H LV+L G
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 71
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+ LV+EF+ + L D L
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL 93
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 33.9 bits (76), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G V+ G + VA+K + D F E ++ ++H LV+L G
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 69
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+ LV+EF+ + L D L
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYL 91
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 33.9 bits (76), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G V+ G + VA+K + D F E ++ ++H LV+L G
Sbjct: 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 74
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+ LV+EF+ + L D L
Sbjct: 75 LEQAPICLVFEFMEHGCLSDYL 96
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 33.9 bits (76), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G V+ G + VA+K + D F E ++ ++H LV+L G
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 71
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+ LV+EF+ + L D L
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL 93
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 7/96 (7%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDH 311
F + E A S +LGQG G VY+G G VA+K + + +
Sbjct: 6 FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347
F NE +++ N ++V+LLG G +L++ E +
Sbjct: 66 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 101
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 33.5 bits (75), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG +
Sbjct: 201 IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 337 GPESL-LVYEFVPNQSLLDNL 356
L +V E++ SL+D L
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL 278
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 33.5 bits (75), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG +
Sbjct: 29 IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 337 GPESL-LVYEFVPNQSLLDNL 356
L +V E++ SL+D L
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYL 106
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 33.5 bits (75), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 12/86 (13%)
Query: 271 FHESNKLGQGGSGSVYKGT---------LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG 321
F+ES LGQG ++KG L E V +K L + + FF +++S
Sbjct: 12 FNES--LGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 322 INHKNLVKLLGCSITGPESLLVYEFV 347
++HK+LV G G E++LV EFV
Sbjct: 69 LSHKHLVLNYGVCFCGDENILVQEFV 94
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 337 GPESL-LVYEFVPNQSLLDNL 356
L +V E++ SL+D L
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL 91
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPGG------EAVAVKRLFYNTTQWVD-HFFNEVN 317
E N +G+G G V++ PG VAVK L + + F E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
L++ ++ N+VKLLG G L++E++
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 132
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V G G + VAVK + + T F E ++++ + H NLV+LLG +
Sbjct: 20 IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 337 GPESL-LVYEFVPNQSLLDNL 356
L +V E++ SL+D L
Sbjct: 77 EKGGLYIVTEYMAKGSLVDYL 97
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 33.1 bits (74), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 11/82 (13%)
Query: 277 LGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
LG+G GSV +G L + AV +L ++ + ++ F +E + +H N+++L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 331 LGCSITG-----PESLLVYEFV 347
LG I P+ +++ F+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFM 123
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 33.1 bits (74), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 74 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 103
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 33.1 bits (74), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 75 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 104
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 33.1 bits (74), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 11 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 71 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 100
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 33.1 bits (74), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 6 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 66 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 95
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 33.1 bits (74), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
A N++ L ET F + LG G G+VYKG +P GE VA+ L T
Sbjct: 37 APNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT 90
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
+ + +E +++ +++ ++ +LLG +T L+ + +P LLD
Sbjct: 91 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 139
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 32.7 bits (73), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 36/81 (44%), Gaps = 8/81 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
H +G+G G VY G A+K L T Q V+ F E L+ G+NH N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 327 LVKLLGCSITG---PESLLVY 344
++ L+G + P LL Y
Sbjct: 84 VLALIGIMLPPEGLPHVLLPY 104
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 75 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 104
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 74 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 103
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 110
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 32.7 bits (73), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 7/66 (10%)
Query: 269 NYFHESNKLGQGGSG----SVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH 324
Y+ N +G+G G +V KGT A + + F VD F E+ ++ ++H
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDH 65
Query: 325 KNLVKL 330
N+++L
Sbjct: 66 PNIIRL 71
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 32.7 bits (73), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 68 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 97
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 32.7 bits (73), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 68 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 97
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 32.7 bits (73), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 50/113 (44%), Gaps = 11/113 (9%)
Query: 246 GALQVAVNKSKLN----FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEA 295
G L +VN + + + E A S +LGQG G VY+G G
Sbjct: 20 GVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR 79
Query: 296 VAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347
VA+K + + + F NE +++ N ++V+LLG G +L++ E +
Sbjct: 80 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 132
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 32.7 bits (73), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 7/66 (10%)
Query: 269 NYFHESNKLGQGGSG----SVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH 324
Y+ N +G+G G +V KGT A + + F VD F E+ ++ ++H
Sbjct: 26 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDH 82
Query: 325 KNLVKL 330
N+++L
Sbjct: 83 PNIIRL 88
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 32.7 bits (73), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 7/90 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-FYNTTQWVDHFFNEVN 317
E A S +LGQG G VY+G G VA+K + + + F NE +
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFV 347
++ N ++V+LLG G +L++ E +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELM 110
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 32.7 bits (73), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW--VDHFFNEVNLISGINHKNL 327
+ + K+G+G G+V+K E VA+KR+ + E+ L+ + HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 328 VKLLGCSITGPESLLVYEF 346
V+L + + LV+EF
Sbjct: 64 VRLHDVLHSDKKLTLVFEF 82
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 32.3 bits (72), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 5/91 (5%)
Query: 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFF--NEVNLISGINHK 325
+++F ++LG+G + VY+ G + ++ T VD E+ ++ ++H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHP 108
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
N++KL T E LV E V L D +
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRI 139
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 32.3 bits (72), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 20/74 (27%), Positives = 36/74 (48%), Gaps = 1/74 (1%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G VYK G A K + + + ++ + E+ +++ +H +VKLLG
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 335 ITGPESLLVYEFVP 348
+ ++ EF P
Sbjct: 86 YHDGKLWIMIEFCP 99
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 32.3 bits (72), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW--VDHFFNEVNLISGINHKNL 327
+ + K+G+G G+V+K E VA+KR+ + E+ L+ + HKN+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 328 VKLLGCSITGPESLLVYEF 346
V+L + + LV+EF
Sbjct: 64 VRLHDVLHSDKKLTLVFEF 82
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 32.3 bits (72), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 22/85 (25%), Positives = 40/85 (47%), Gaps = 6/85 (7%)
Query: 274 SNKLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
+LG+G G V+ P + VAVK L + F E L++ + H+++
Sbjct: 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL 352
VK G + G ++V+E++ + L
Sbjct: 78 VKFYGVCVEGDPLIMVFEYMKHGDL 102
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 32.3 bits (72), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 20/74 (27%), Positives = 36/74 (48%), Gaps = 1/74 (1%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
+LG G G VYK G A K + + + ++ + E+ +++ +H +VKLLG
Sbjct: 18 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 335 ITGPESLLVYEFVP 348
+ ++ EF P
Sbjct: 78 YHDGKLWIMIEFCP 91
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 32.3 bits (72), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 37/82 (45%), Gaps = 1/82 (1%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
++G G G V+ G + VA+K + D F E ++ ++H LV+L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 72
Query: 335 ITGPESLLVYEFVPNQSLLDNL 356
+ LV EF+ + L D L
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL 94
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 32.0 bits (71), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 7/82 (8%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V G LPG VA+K L Y Q D F +E +++ +H N++ L
Sbjct: 41 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIHL 99
Query: 331 LGCSITGPESLLVYEFVPNQSL 352
G +++ EF+ N SL
Sbjct: 100 EGVVTKSTPVMIITEFMENGSL 121
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 7/82 (8%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V G LPG VA+K L Y Q D F +E +++ +H N++ L
Sbjct: 15 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIHL 73
Query: 331 LGCSITGPESLLVYEFVPNQSL 352
G +++ EF+ N SL
Sbjct: 74 EGVVTKSTPVMIITEFMENGSL 95
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 32.0 bits (71), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 18/57 (31%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
LG+G G VY G L +A+K + +++ E+ L + HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 32.0 bits (71), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 23/86 (26%), Positives = 39/86 (45%), Gaps = 3/86 (3%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGIN 323
+ + + KLG+G G VYK E VA+K RL + EV+L+ +
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPN 349
H+N+++L L++E+ N
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN 117
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 31.6 bits (70), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 18/58 (31%), Positives = 29/58 (50%), Gaps = 1/58 (1%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
LG+G G VY G L +A+K + +++ E+ L + HKN+V+ LG
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 31.6 bits (70), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 15/59 (25%), Positives = 31/59 (52%), Gaps = 1/59 (1%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+LG G G VYK +A ++ + + ++ + E+++++ +H N+VKLL
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 31.6 bits (70), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 15/59 (25%), Positives = 31/59 (52%), Gaps = 1/59 (1%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+LG G G VYK +A ++ + + ++ + E+++++ +H N+VKLL
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 31.6 bits (70), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 15/59 (25%), Positives = 31/59 (52%), Gaps = 1/59 (1%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
+LG G G VYK +A ++ + + ++ + E+++++ +H N+VKLL
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 31.6 bits (70), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 1/65 (1%)
Query: 291 PGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349
P E VA+KR+ Q +D E+ +S +H N+V + E LV + +
Sbjct: 38 PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 350 QSLLD 354
S+LD
Sbjct: 98 GSVLD 102
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 31.6 bits (70), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 1/65 (1%)
Query: 291 PGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN 349
P E VA+KR+ Q +D E+ +S +H N+V + E LV + +
Sbjct: 33 PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 350 QSLLD 354
S+LD
Sbjct: 93 GSVLD 97
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 31.6 bits (70), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 2/66 (3%)
Query: 293 GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVYEFVPNQ 350
G VAVK+L ++ F E+ ++ ++ +VK G S PE LV E++P+
Sbjct: 36 GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSG 95
Query: 351 SLLDNL 356
L D L
Sbjct: 96 CLRDFL 101
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 31.2 bits (69), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTL--PGGEA--VAVKRLF--YNTTQWVDHFFNEVNL 318
E +Y +G G G V +G L PG + VA+K L Y Q F +E ++
Sbjct: 10 EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASI 68
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352
+ H N+++L G +++ EF+ N +L
Sbjct: 69 MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 102
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 31.2 bits (69), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 15/92 (16%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
++KSK++ + ++E A + F + +G G G V + L G VAVK+L
Sbjct: 1 MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS 58
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
F N T + E+ L+ +NHKN++ LL
Sbjct: 59 RPFQNQTH-AKRAYRELVLLKCVNHKNIISLL 89
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 31.2 bits (69), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 5/93 (5%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTL--PGGEA--VAVKRLFYN-TTQWVDHFFNEVNLI 319
E +Y +G G G V +G L PG + VA+K L T + F +E +++
Sbjct: 12 EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 71
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSL 352
H N+++L G +++ EF+ N +L
Sbjct: 72 GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 31.2 bits (69), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 23/90 (25%), Positives = 43/90 (47%), Gaps = 3/90 (3%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFF--NEVNLISGINHKN 326
+Y+ +LG G G V++ V V + F NT +D + NE+++++ ++H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAK-FINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
L+ L E +L+ EF+ L D +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI 139
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 30.8 bits (68), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 20/64 (31%), Positives = 31/64 (48%), Gaps = 5/64 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
F E +G GG G V+K G+ +KR+ YN + EV ++ ++H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIVH 68
Query: 330 LLGC 333
GC
Sbjct: 69 YNGC 72
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 30.4 bits (67), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 29/118 (24%), Positives = 54/118 (45%), Gaps = 7/118 (5%)
Query: 247 ALQVAVNKSKLNFSYETL---EKATNYFHESNK---LGQGGSGSVYK-GTLPGGEAVAVK 299
AL V + F + + + A N F+ +K LG G G V+K G +A K
Sbjct: 61 ALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK 120
Query: 300 RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
+ + + NE+++++ ++H NL++L + + +LV E+V L D +
Sbjct: 121 IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 30.4 bits (67), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 15/108 (13%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
V ++ ++L + ++ E N LG G G V + T G VAVK L
Sbjct: 21 VXIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 79
Query: 302 -FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEF 346
+ T + + +E+ ++S + NH N+V LLG C+I GP +L++ E+
Sbjct: 80 SAHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEY 124
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 5/82 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V K + VA+K++ + + F E+ +S +NH N+VKL G +
Sbjct: 17 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 337 GPESLLVYEFVPNQSLLDNLFG 358
LV E+ SL + L G
Sbjct: 74 --PVCLVMEYAEGGSLYNVLHG 93
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 5/82 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
+G+G G V K + VA+K++ + + F E+ +S +NH N+VKL G +
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 337 GPESLLVYEFVPNQSLLDNLFG 358
LV E+ SL + L G
Sbjct: 73 --PVCLVMEYAEGGSLYNVLHG 92
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/68 (32%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G+ VAVK + TQ + F EV ++ +NH N+VKL T LV E+
Sbjct: 39 GKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 97 GGEVFDYL 104
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 5/64 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
F E +G GG G V+K G+ ++R+ YN + EV ++ ++H N+V
Sbjct: 14 FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIVH 69
Query: 330 LLGC 333
GC
Sbjct: 70 YNGC 73
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/68 (32%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G+ VAVK + TQ + F EV ++ +NH N+VKL T LV E+
Sbjct: 39 GKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 97 GGEVFDYL 104
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/68 (32%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G+ VAVK + TQ + F EV ++ +NH N+VKL T LV E+
Sbjct: 39 GKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 97 GGEVFDYL 104
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 30.0 bits (66), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 293 GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESL-LVYEFVPNQ 350
G VAVK+L ++ F E+ ++ ++ +VK G S G +SL LV E++P+
Sbjct: 52 GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 351 SLLDNL 356
L D L
Sbjct: 112 CLRDFL 117
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 30.0 bits (66), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 293 GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESL-LVYEFVPNQ 350
G VAVK+L ++ F E+ ++ ++ +VK G S G +SL LV E++P+
Sbjct: 40 GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 351 SLLDNL 356
L D L
Sbjct: 100 CLRDFL 105
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 30.0 bits (66), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 293 GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESL-LVYEFVPNQ 350
G VAVK+L ++ F E+ ++ ++ +VK G S G +SL LV E++P+
Sbjct: 39 GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 351 SLLDNL 356
L D L
Sbjct: 99 CLRDFL 104
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 22/68 (32%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G+ VAVK + TQ + F EV ++ +NH N+VKL T LV E+
Sbjct: 32 GKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 89
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 90 GGEVFDYL 97
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 30.0 bits (66), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 6/85 (7%)
Query: 274 SNKLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
+LG+G G V+ P + VAVK L T F E L++ + H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL 352
VK G G ++V+E++ + L
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDL 104
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 30.0 bits (66), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFY 303
V ++ ++L + ++ E N LG G G V + T G VAVK L
Sbjct: 5 VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 304 NT-TQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEF 346
+ + +E+ ++S + NH N+V LLG C+I GP +L++ E+
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEY 108
>pdb|2POS|A Chain A, Crystal Structure Of Sylvaticin, A New Secreted Protein
From Pythium Sylvaticum
pdb|2POS|B Chain B, Crystal Structure Of Sylvaticin, A New Secreted Protein
From Pythium Sylvaticum
pdb|2POS|C Chain C, Crystal Structure Of Sylvaticin, A New Secreted Protein
From Pythium Sylvaticum
pdb|2POS|D Chain D, Crystal Structure Of Sylvaticin, A New Secreted Protein
From Pythium Sylvaticum
pdb|2PR0|A Chain A, Crystal Structure Of Sylvaticin, A New Secreted Protein
From Pythium Sylvaticum
pdb|2PR0|B Chain B, Crystal Structure Of Sylvaticin, A New Secreted Protein
From Pythium Sylvaticum
Length = 94
Score = 30.0 bits (66), Expect = 2.3, Method: Composition-based stats.
Identities = 13/33 (39%), Positives = 18/33 (54%)
Query: 21 GTASVYAFGECMKDLSPNDCNLCFAQCKTQVLK 53
GTA + + +K L+PNDC L F + V K
Sbjct: 52 GTAECFTLIDAIKALNPNDCILVFGDVRLNVKK 84
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 29.6 bits (65), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 22/68 (32%), Positives = 30/68 (44%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G VAVK + TQ + F EV ++ +NH N+VKL T LV E+
Sbjct: 40 GREVAVK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYAS 97
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 98 GGEVFDYL 105
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 29.6 bits (65), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 15/108 (13%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
V ++ ++L + ++ E N LG G G V + T G VAVK L
Sbjct: 23 VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 81
Query: 302 -FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEF 346
+ T + + +E+ ++S + NH N+V LLG C+I GP +L++ E+
Sbjct: 82 SAHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEY 126
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 29.6 bits (65), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 20/83 (24%), Positives = 39/83 (46%), Gaps = 3/83 (3%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
++ F KLG+G GSVYK G+ VA+K++ + + E++++ +
Sbjct: 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCD 82
Query: 324 HKNLVKLLGCSITGPESLLVYEF 346
++VK G + +V E+
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEY 105
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 29.6 bits (65), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 6/77 (7%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G G VY+G T GE VAVK + T + F +E ++ ++H ++VKL+
Sbjct: 16 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 332 GCSITGPESLLVYEFVP 348
G P + ++ E P
Sbjct: 76 GIIEEEP-TWIIMELYP 91
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 29.6 bits (65), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 15/108 (13%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
V ++ ++L + ++ E N LG G G V + T G VAVK L
Sbjct: 28 VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 86
Query: 302 -FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEF 346
+ T + + +E+ ++S + NH N+V LLG C+I GP +L++ E+
Sbjct: 87 SAHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEY 131
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 29.6 bits (65), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 6/77 (7%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G G VY+G T GE VAVK + T + F +E ++ ++H ++VKL+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 332 GCSITGPESLLVYEFVP 348
G P + ++ E P
Sbjct: 80 GIIEEEP-TWIIMELYP 95
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 29.6 bits (65), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 15/108 (13%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
V ++ ++L + ++ E N LG G G V + T G VAVK L
Sbjct: 28 VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 86
Query: 302 -FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEF 346
+ T + + +E+ ++S + NH N+V LLG C+I GP +L++ E+
Sbjct: 87 SAHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEY 131
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 29.3 bits (64), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 6/77 (7%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL 331
LG+G G VY+G T GE VAVK + T + F +E ++ ++H ++VKL+
Sbjct: 32 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 332 GCSITGPESLLVYEFVP 348
G P + ++ E P
Sbjct: 92 GIIEEEP-TWIIMELYP 107
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 29.3 bits (64), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G+ VAV+ + TQ + F EV ++ +NH N+VKL T LV E+
Sbjct: 39 GKEVAVR--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 97 GGEVFDYL 104
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 29.3 bits (64), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G+ VAV+ + TQ + F EV ++ +NH N+VKL T LV E+
Sbjct: 39 GKEVAVR--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 97 GGEVFDYL 104
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 29.3 bits (64), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 30/68 (44%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G VA+K + TQ + F EV ++ +NH N+VKL T L+ E+
Sbjct: 40 GREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 98 GGEVFDYL 105
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 29.3 bits (64), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 30/68 (44%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G VA+K + TQ + F EV ++ +NH N+VKL T L+ E+
Sbjct: 37 GREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 94
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 95 GGEVFDYL 102
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 29.3 bits (64), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 9/63 (14%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKXVNHKNIISL 88
Query: 331 LGC 333
L
Sbjct: 89 LNV 91
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 28.9 bits (63), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 13/53 (24%), Positives = 26/53 (49%)
Query: 304 NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
N ++ + +NE++L+ ++H N++KL LV EF L + +
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI 137
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 28.9 bits (63), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 36/75 (48%), Gaps = 2/75 (2%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
+KLG+G +VYKG + VA+K + + EV+L+ + H N+V L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 333 CSITGPESLLVYEFV 347
T LV+E++
Sbjct: 68 IIHTEKSLTLVFEYL 82
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 28.9 bits (63), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 9/63 (14%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKXVNHKNIISL 88
Query: 331 LGC 333
L
Sbjct: 89 LNV 91
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 28.9 bits (63), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 22/68 (32%), Positives = 30/68 (44%), Gaps = 6/68 (8%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
G+ VAVK + TQ + F EV + +NH N+VKL T LV E+
Sbjct: 39 GKEVAVK--IIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYAS 96
Query: 349 NQSLLDNL 356
+ D L
Sbjct: 97 GGEVFDYL 104
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 28.9 bits (63), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 9/63 (14%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKXVNHKNIISL 88
Query: 331 LGC 333
L
Sbjct: 89 LNV 91
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 28.5 bits (62), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 15/92 (16%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
++KSK++ + ++E + F +G G G V Y L VA+K+L
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 96
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
F N T + E+ L+ +NHKN++ LL
Sbjct: 97 RPFQNQTH-AKRAYRELVLMKCVNHKNIISLL 127
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 28.5 bits (62), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 27/102 (26%), Positives = 41/102 (40%), Gaps = 9/102 (8%)
Query: 248 LQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA-VAVKRLFYNTT 306
L AV K K ++E L ++G+G G V+ G L VAVK
Sbjct: 100 LHRAVPKDKWVLNHEDLVLG-------EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152
Query: 307 QWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347
+ F E ++ +H N+V+L+G +V E V
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 28.5 bits (62), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 27/102 (26%), Positives = 41/102 (40%), Gaps = 9/102 (8%)
Query: 248 LQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA-VAVKRLFYNTT 306
L AV K K ++E L ++G+G G V+ G L VAVK
Sbjct: 100 LHRAVPKDKWVLNHEDLVLG-------EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152
Query: 307 QWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347
+ F E ++ +H N+V+L+G +V E V
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 28.5 bits (62), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 21/97 (21%), Positives = 40/97 (41%), Gaps = 7/97 (7%)
Query: 247 ALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT 306
A Q ++ + + +E LE +G+G G VY G G A+ + + +
Sbjct: 18 ASQTSIFLQEWDIPFEQLEIG-------ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNE 70
Query: 307 QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343
+ F EV H+N+V +G ++ P ++
Sbjct: 71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 28.5 bits (62), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 15/92 (16%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
++KSK++ + ++E + F +G G G V Y L VA+K+L
Sbjct: 1 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
F N T + E+ L+ +NHKN++ LL
Sbjct: 59 RPFQNQTH-AKRAYRELVLMKCVNHKNIISLL 89
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 28.1 bits (61), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 22/67 (32%), Positives = 33/67 (49%), Gaps = 9/67 (13%)
Query: 271 FHESNKLGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINH 324
+ + +G G G V + L G VAVK+L F N T + E+ L+ +NH
Sbjct: 24 YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNH 80
Query: 325 KNLVKLL 331
KN++ LL
Sbjct: 81 KNIISLL 87
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 28.1 bits (61), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 15/92 (16%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
++KSK++ + ++E + F +G G G V Y L VA+K+L
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 96
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
F N T + E+ L+ +NHKN++ LL
Sbjct: 97 RPFQNQTH-AKRAYRELVLMKCVNHKNIISLL 127
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 28.1 bits (61), Expect = 7.6, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 9/61 (14%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 89
Query: 331 L 331
L
Sbjct: 90 L 90
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 28.1 bits (61), Expect = 7.9, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 9/61 (14%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 88
Query: 331 L 331
L
Sbjct: 89 L 89
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 28.1 bits (61), Expect = 7.9, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
++ ++L ++ E E N LG G G V + T G G+ AV ++ +
Sbjct: 15 IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 73
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF 346
H +E+ ++S + H+N+V LLG G L++ E+
Sbjct: 74 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 116
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 28.1 bits (61), Expect = 8.1, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 9/61 (14%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 31 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 87
Query: 331 L 331
L
Sbjct: 88 L 88
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 28.1 bits (61), Expect = 8.1, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
++ ++L ++ E E N LG G G V + T G G+ AV ++ +
Sbjct: 30 IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF 346
H +E+ ++S + H+N+V LLG G L++ E+
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 28.1 bits (61), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
++ ++L ++ E E N LG G G V + T G G+ AV ++ +
Sbjct: 30 IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF 346
H +E+ ++S + H+N+V LLG G L++ E+
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 28.1 bits (61), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
++ ++L ++ E E N LG G G V + T G G+ AV ++ +
Sbjct: 22 IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 80
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF 346
H +E+ ++S + H+N+V LLG G L++ E+
Sbjct: 81 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 123
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 28.1 bits (61), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
++ ++L ++ E E N LG G G V + T G G+ AV ++ +
Sbjct: 30 IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF 346
H +E+ ++S + H+N+V LLG G L++ E+
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 28.1 bits (61), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 9/61 (14%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 89
Query: 331 L 331
L
Sbjct: 90 L 90
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 28.1 bits (61), Expect = 8.7, Method: Compositional matrix adjust.
Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 9/63 (14%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
+G G G V Y L VA+K+L F N T + E+ L+ +NHKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 88
Query: 331 LGC 333
L
Sbjct: 89 LNV 91
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.136 0.418
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,260,789
Number of Sequences: 62578
Number of extensions: 363754
Number of successful extensions: 1455
Number of sequences better than 100.0: 373
Number of HSP's better than 100.0 without gapping: 147
Number of HSP's successfully gapped in prelim test: 226
Number of HSP's that attempted gapping in prelim test: 1194
Number of HSP's gapped (non-prelim): 373
length of query: 359
length of database: 14,973,337
effective HSP length: 100
effective length of query: 259
effective length of database: 8,715,537
effective search space: 2257324083
effective search space used: 2257324083
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 52 (24.6 bits)